Bridee A Neibling1, Sarah M Jackson2,3, Kathryn S Hayward3,4,5,6, Ruth N Barker7. 1. College of Healthcare Sciences, James Cook University, Townsville, QLD, 4811, Australia. bridee.neibling@my.jcu.edu.au. 2. College of Healthcare Sciences, James Cook University, Townsville, QLD, 4811, Australia. 3. Centre for Rural and Remote Health, James Cook University, Mount Isa, QLD, 4825, Australia. 4. Melbourne School of Health Sciences, University of Melbourne, Melbourne, VIC, 3084, Australia. 5. Stroke Theme, Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, 3084, Australia. 6. NHMRC CRE in Stroke Rehabilitation and Brain Recovery, Melbourne, VIC, 3084, Australia. 7. College of Healthcare Sciences, James Cook University, Cairns, QLD, 4878, Australia.
Abstract
BACKGROUND: Technology is being increasingly investigated as an option to allow stroke survivors to exploit their full potential for recovery by facilitating home-based upper limb practice. This review seeks to explore the factors that influence perseverance with technology-facilitated home-based upper limb practice after stroke. METHODS: A systematic mixed studies review with sequential exploratory synthesis was undertaken. Studies investigating adult stroke survivors with upper limb disability undertaking technology-facilitated home-based upper limb practice administered ≥ 3 times/week over a period of ≥ 4 weeks were included. Qualitative outcomes were stroke survivors' and family members' perceptions of their experience utilising technology to facilitate home-based upper limb practice. Quantitative outcomes were adherence and dropouts, as surrogate measures of perseverance. The Mixed Methods Appraisal Tool was used to assess quality of included studies. RESULTS: Forty-two studies were included. Six studies were qualitative and of high quality; 28 studies were quantitative and eight were mixed methods studies, all moderate to low quality. A conceptual framework of perseverance with three stages was formed: (1) getting in the game; (2) sticking with it, and; (3) continuing or moving on. Conditions perceived to influence perseverance, and factors mediating these conditions were identified at each stage. Adherence with prescribed dose ranged from 13 to 140%. Participants were found to be less likely to adhere when prescribed sessions were more frequent (6-7 days/week) or of longer duration (≥ 12 weeks). CONCLUSION: From the mixed methods findings, we propose a framework for perseverance with technology-facilitated home-based upper limb practice. The framework offers opportunities for clinicians and researchers to design strategies targeting factors that influence perseverance with practice, in both the clinical prescription of practice and technology design. To confirm the clinical utility of this framework, further research is required to explore perseverance and the factors influencing perseverance. Registration: PROSPERO CRD42017072799- https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=72799.
BACKGROUND: Technology is being increasingly investigated as an option to allow stroke survivors to exploit their full potential for recovery by facilitating home-based upper limb practice. This review seeks to explore the factors that influence perseverance with technology-facilitated home-based upper limb practice after stroke. METHODS: A systematic mixed studies review with sequential exploratory synthesis was undertaken. Studies investigating adult stroke survivors with upper limb disability undertaking technology-facilitated home-based upper limb practice administered ≥ 3 times/week over a period of ≥ 4 weeks were included. Qualitative outcomes were stroke survivors' and family members' perceptions of their experience utilising technology to facilitate home-based upper limb practice. Quantitative outcomes were adherence and dropouts, as surrogate measures of perseverance. The Mixed Methods Appraisal Tool was used to assess quality of included studies. RESULTS: Forty-two studies were included. Six studies were qualitative and of high quality; 28 studies were quantitative and eight were mixed methods studies, all moderate to low quality. A conceptual framework of perseverance with three stages was formed: (1) getting in the game; (2) sticking with it, and; (3) continuing or moving on. Conditions perceived to influence perseverance, and factors mediating these conditions were identified at each stage. Adherence with prescribed dose ranged from 13 to 140%. Participants were found to be less likely to adhere when prescribed sessions were more frequent (6-7 days/week) or of longer duration (≥ 12 weeks). CONCLUSION: From the mixed methods findings, we propose a framework for perseverance with technology-facilitated home-based upper limb practice. The framework offers opportunities for clinicians and researchers to design strategies targeting factors that influence perseverance with practice, in both the clinical prescription of practice and technology design. To confirm the clinical utility of this framework, further research is required to explore perseverance and the factors influencing perseverance. Registration: PROSPERO CRD42017072799- https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=72799.
Authors: Gert Kwakkel; Roland van Peppen; Robert C Wagenaar; Sharon Wood Dauphinee; Carol Richards; Ann Ashburn; Kimberly Miller; Nadina Lincoln; Cecily Partridge; Ian Wellwood; Peter Langhorne Journal: Stroke Date: 2004-10-07 Impact factor: 7.914
Authors: Yu Chen; Kingsley Travis Abel; John T Janecek; Yunan Chen; Kai Zheng; Steven C Cramer Journal: Int J Med Inform Date: 2018-12-11 Impact factor: 4.046
Authors: Alison R Buick; Jan Kowalczewski; Richard G Carson; Arthur Prochazka Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2015-03-11 Impact factor: 3.802
Authors: Marti Comellas; Vicky Chan; Daniel K Zondervan; David J Reinkensmeyer Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2022-07-14 Impact factor: 4.528
Authors: Marios Spanakis; Ioanna Xylouri; Evridiki Patelarou; Athina Patelarou Journal: Int J Environ Res Public Health Date: 2022-07-28 Impact factor: 4.614
Authors: Edgar De Jesus Ramos Muñoz; Veronica Ann Swanson; Christopher Johnson; Raeda K Anderson; Amanda R Rabinowitz; Daniel K Zondervan; George H Collier; David J Reinkensmeyer Journal: Front Neurol Date: 2022-06-20 Impact factor: 4.086